Article

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies

2023-08-03

Abstract excerpt

Protein kinases are a primary focus in targeted therapy development for cancer, owing to their role as regulators in nearly all areas of cell life. Kinase inhibitors are one of the fastest growing drug classes in oncology, but resistance acquisition to kinase-targeting monotherapies is inevitable due to the dynamic and interconnected nature of the kinome in response to perturbation. Recent strategies targeting the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69fc2140-17f4-5a16-b933-a61afd65fd8d
DOI: 10.1101/2023.08.01.551346

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapiesDOI 10.1101/2023.08.01.551346Read

Integrated Single-Dose Kinome Profiling Data is Predictive of Cancer Cell Line Sensitivity to Kinase InhibitorsSemantic proximity Read

Kinome-centric pharmacoproteomics identifies signaling pathways underlying cellular responses to targeted cancer drugsSemantic proximity Read

Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017Semantic proximity Read

Anticancer Target Combinations: Network-Informed Signaling-Based Approach to DiscoverySemantic proximity Read

Personalized Network Modeling of the Pan-Cancer Patient and Cell Line InteractomeSemantic proximity Read

Tumor cell sensitivity to vemurafenib can be predicted from protein expression in a BRAF-V600E basket trial setting.Semantic proximity Read

Predicting Tumor Response to Drugs based on Gene-Expression Biomarkers of Sensitivity Learned from Cancer Cell LinesSemantic proximity Read

Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.Semantic proximity Read

Predicting Tumor Response to Drugs Based on Gene-expression Biomarkers of Sensitivity Learned From Cancer Cell LinesSemantic proximity Read

A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination predictionSemantic proximity Read

A Community Challenge for Pancancer Drug Mechanism of Action Inference from Perturbational Profile DataSemantic proximity Read

HEPATOCELLULAR CARCINOMA KINOME ATLAS AS AN EMPLOYABLE INSTRUMENTED PERSONALIZED MEDICINESemantic proximity Read